Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Ninane

Showing results (101-110 of 116) with videos related to

Pageof 12
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2002
A three-arm phase III randomised trial comparing combinations of platinum derivatives, ifosfamide and/or gemcitabine in stage IV non-small-cell lung cancerJ P Sculier, J J Lafitte, J Lecomte, et al.
Lung Cancer (Amsterdam, Netherlands)|January 8, 2004
Consensus: the follow-up of the treated patientM Saunders, J P Sculier, D Ball, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. European Lung Cancer Working PartyJ P Sculier, M Paesmans, J Thiriaux, et al.
British Journal of Cancer|October 12, 2000
Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancerJ P Sculier, J J Lafitte, M Paesmans, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2000
A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer. European Lung Cancer Working PartyJ P Sculier, M Paesmans, J Thiriaux, et al.
Lung Cancer (Amsterdam, Netherlands)|January 8, 2004
Critical factors for patient managementV Ninane, C Le Pechoux, W Curran, et al.
Lung Cancer (Amsterdam, Netherlands)|August 11, 2004
Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapyT Berghmans, J J Lafitte, J Thiriaux, et al.
Clinical Rehabilitation|April 25, 2009
A clinical practice guideline for physiotherapists treating patients with chronic obstructive pulmonary disease based on a systematic review of available evidenceD Langer, Ejm Hendriks, C Burtin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 4, 2007
A phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancerJ P Sculier, J J Lafitte, J Lecomte, et al.
Revue Des Maladies Respiratoires|November 26, 2003
[Three challenges for the journal]T Similowski, B Fauroux, V Ninane, et al.
Pageof 12

Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2002
A three-arm phase III randomised trial comparing combinations of platinum derivatives, ifosfamide and/or gemcitabine in stage IV non-small-cell lung cancerJ P Sculier, J J Lafitte, J Lecomte, et al.
Lung Cancer (Amsterdam, Netherlands)|January 8, 2004
Consensus: the follow-up of the treated patientM Saunders, J P Sculier, D Ball, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. European Lung Cancer Working PartyJ P Sculier, M Paesmans, J Thiriaux, et al.
British Journal of Cancer|October 12, 2000
Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancerJ P Sculier, J J Lafitte, M Paesmans, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2000
A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer. European Lung Cancer Working PartyJ P Sculier, M Paesmans, J Thiriaux, et al.
Lung Cancer (Amsterdam, Netherlands)|January 8, 2004
Critical factors for patient managementV Ninane, C Le Pechoux, W Curran, et al.
Lung Cancer (Amsterdam, Netherlands)|August 11, 2004
Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapyT Berghmans, J J Lafitte, J Thiriaux, et al.
Clinical Rehabilitation|April 25, 2009
A clinical practice guideline for physiotherapists treating patients with chronic obstructive pulmonary disease based on a systematic review of available evidenceD Langer, Ejm Hendriks, C Burtin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 4, 2007
A phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancerJ P Sculier, J J Lafitte, J Lecomte, et al.
Revue Des Maladies Respiratoires|November 26, 2003
[Three challenges for the journal]T Similowski, B Fauroux, V Ninane, et al.
Pageof 12